Abstract: A method for smelting low-phosphorus high-manganese steel based on reduction dephosphorization of ferromanganese is provided in the present application, relating to the technical field of high-manganese steel smelting, where the dephosphorization of ferromanganese is carried out under reducing atmosphere conditions through mediate-frequency induction furnace to obtain molten ferromanganese with lower phosphorus content, which is subsequently mixed with low phosphorus molten steel obtained by smelting in oxidative period of electric arc furnace in LF ladle refining furnace to make the Mn content of steel reach the requirement of high-manganese steel, and smelting is carried out under the condition of reducing atmosphere by adjusting the composition and temperature of the molten steel to meet the requirements of the target composition of the steel grade before tapping the steel.

Abstract: Provided are high concentration stable formulations of anti-CSF1R/CSF1 antibodies. An example formulation includes 105 to 250 mg/mL of the antibody, 100 mM to 200 mM of arginine glutamate or arginine HCl, 10 mM to 50 mM histidine, and 0.015 to 0.035 w/v % of polysorbate 80, at a pH of 5.4 to 5.6. Also provided are methods of using the formulations for treating diseases.

Abstract: The embodiments of the present disclosure provide a display panel, a manufacturing method thereof, and a display device. The display panel includes a first substrate and a second substrate cell-assembled to each other, a light emitting member layer disposed between the first substrate and the second substrate and a light diffusion layer disposed on a light existing side of the light emitting member layer, the light emitting member layer includes a plurality of light emitting units and imaging holes disposed on at least two sides of each of the light emitting units, the light diffusion layer includes a reflective member configured to reflect a light ray emitted by the light emitting unit and reaching the reflective member, and the reflected light ray reflected by the reflective member exits from the imaging holes.

Abstract: A backlight assembly and a display device including the backlight assembly are provided. The backlight assembly includes a light source unit, a peep-proof layer on a light emitting side of the light source unit, a light adjustment layer on a side of the peep-proof layer distal to the light source unit, and a plurality of first microstructures between the peep-proof layer and the light adjustment layer and spaced apart from each other.

Abstract: Provided are high concentration stable formulations of anti-CSF1R/CSF1 antibodies. An example formulation includes 105 to 250 mg/mL of the antibody, 100 mM to 200 mM of arginine glutamate or arginine HCl, 10 mM to 50 mM histidine, and 0.015 to 0.035 w/v % of polysorbate 80, at a pH of 5.4 to 5.6. Also provided are methods of using the formulations for treating diseases.

Abstract: A display panel configured to display images is provided, each image including a plurality of image pixels and each image pixel including a plurality of sub-pixels of different colors, respectively, the display panel including: a base substrate; and a plurality of sub-beam generation components on the base substrate, each sub-beam generation component being configured to generate at least one sub-pixel in at least one image pixel of the image pixels and including: a group of light-emitting units comprising at least one light-emitting unit and corresponding to at least one sub-pixel; and a beam-expanding layer, which is arranged on a light emergent side of the group of light-emitting units and configured to expand light beams emitted from the group of light-emitting units; an orthogonal projection of the beam-expanding layer on the base substrate at least partially overlapping with an orthogonal projection of the group of light-emitting units on the base substrate.

Abstract: Provided are high concentration stable formulations of anti-CSF1R/CSF1 antibodies. An example formulation includes 105 to 250 mg/mL of the antibody, 100 mM to 200 mM of arginine glutamate or arginine HCl, 10 mM to 50 mM histidine, and 0.015 to 0.035 w/v % of polysorbate 80, at a pH of 5.4 to 5.6. Also provided are methods of using the formulations for treating diseases.

Abstract: An apparatus for controlling a degradation rate of an artificial bone in vitro, a degradation method, and an artificial bone are disclosed. The apparatus includes: a variable resistor; and a wearable component, comprising: a metal wire electrically connected in series with the variable resistor and configured to generate an alternating magnetic field; and an insulating textile layer by which the outside of the metal wire is covered.

Abstract: A backlight assembly and a display device including the backlight assembly are provided. The backlight assembly includes a light source unit, a peep-proof layer on a light emitting side of the light source unit, a light adjustment layer on a side of the peep-proof layer distal to the light source unit, and a plurality of first microstructures between the peep-proof layer and the light adjustment layer and spaced apart from each other.

Abstract: The embodiments of the resent disclosure provide a display pane, a manufacturing method thereof, and a display device. The display panel includes a first substrate and a second substrate cell-assembled to each other, a light emitting member layer disposed between the first substrate and the second substrate and a light diffusion layer disposed on a light exiting side of the light emitting member layer, the light emitting member layer includes a plurality of light emitting units and imaging holes disposed on at least two sides of each of the light emitting units, the light diffusion layer includes a reflective member configured to reflect a light ray emitted by the light emitting unit and reaching the reflective member, and the reflected light ray reflected by the reflective member exits from the imaging holes.

Abstract: A display panel which is configured to display images is provided in embodiments of the disclosure, each image including a plurality of image pixels and each image pixel including a plurality of sub-pixels of different colors, respectively, the display panel including: a base substrate; and a plurality of sub-beam generation components on the base substrate, each sub-beam generation component being configured to generate at least one sub-pixel in at least one image pixel of the plurality of image pixels and including: a group of light-emitting units comprising at least one light-emitting unit and corresponding to at least one sub-pixel; and a beam-expanding layer, which is arranged on a light emergent side of the group of light-emitting units and configured to expand light beams emitted from the group of light-emitting units; an orthogonal projection of the beam-expanding layer on the base substrate at least partially overlapping with an orthogonal projection of the group of light-emitting units on the base s

Abstract: An apparatus for controlling a degradation rate of an artificial bone in vitro, a degradation method, and an artificial bone are disclosed. The apparatus includes: a variable resistor; and a wearable component, comprising: a metal wire electrically connected in series with the variable resistor and configured to generate an alternating magnetic field; and an insulating textile layer by which the outside of the metal wire is covered.

Abstract: An apparatus includes a filtration skid configured to generate a filtrate through at least one of microfiltration and ultrafiltration. The apparatus further includes a desalination skid fluidly connected to the filtration skid. The desalination skid is configured to perform reverse osmosis desalination on the filtrate to generate a permeate, where the filtrate travels from the filtration skid to the desalination skid without traversing a storage tank. In one embodiment, the apparatus further comprises a controller, where the filtration skid and the desalination skid are integrated to provide self-adaptive operation of the filtration skid and the desalination skid in response to control by at least one of a supervisory controller and a local controller. In one embodiment, the control responds to at least one of temporal variability of feed water quality, a permeate production capacity target, and a permeate quality target.

Abstract: An apparatus includes a filtration skid configured to generate a filtrate through at least one of microfiltration and ultrafiltration. The apparatus further includes a desalination skid fluidly connected to the filtration skid. The desalination skid is configured to perform reverse osmosis desalination on the filtrate to generate a permeate, where the filtrate travels from the filtration skid to the desalination skid without traversing a storage tank. In one embodiment, the apparatus further comprises a controller, where the filtration skid and the desalination skid are integrated to provide self-adaptive operation of the filtration skid and the desalination skid in response to control by at least one of a supervisory controller and a local controller. In one embodiment, the control responds to at least one of temporal variability of feed water quality, a permeate production capacity target, and a permeate quality target.